Who are ropivacaine, ketorelac and epinephrine's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ropivacaine-ketorelac-and-epinephrine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

ropivacaine, ketorelac and epinephrine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ropivacaine, ketorelac and epinephrine (ropivacaine, ketorelac and epinephrine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic and NSAID. Area: Pain management.

phase 3 Local anesthetic and NSAID Sodium channels and prostaglandin synthesis Pain management Small molecule Live · refreshed every 30 min

Target snapshot

ropivacaine, ketorelac and epinephrine (ropivacaine, ketorelac and epinephrine) — Region Örebro County. Ropivacaine is a local anesthetic that blocks nerve impulses, while ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation, and epinephrine is a vasoconstrictor that helps to prolong the duration of action of ropivacaine.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
ropivacaine, ketorelac and epinephrine TARGET	ropivacaine, ketorelac and epinephrine	Region Örebro County	phase 3	Local anesthetic and NSAID	Sodium channels and prostaglandin synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic and NSAID class)

Region Örebro County · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ropivacaine, ketorelac and epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-ketorelac-and-epinephrine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab